Loading
Latest filing published 26 Oct 2018 for Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.).
No signal scores available.
Patrick Rolfes is a declared insider of Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.), with filings sourced from SEDI. Between 1 March 2018 and 3 May 2018, the trades on record add up to 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 26 October 2018: a share grant, in Pivot Pharmaceuticals Inc. (formerly Neurokine Pharmaceuticals Inc.). Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations